Your browser doesn't support javascript.
loading
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.
Kawakami, Masanori; Mustachio, Lisa Maria; Rodriguez-Canales, Jaime; Mino, Barbara; Roszik, Jason; Tong, Pan; Wang, Jing; Lee, J Jack; Myung, Ja Hye; Heymach, John V; Johnson, Faye M; Hong, Seungpyo; Zheng, Lin; Hu, Shanhu; Villalobos, Pamela Andrea; Behrens, Carmen; Wistuba, Ignacio; Freemantle, Sarah; Liu, Xi; Dmitrovsky, Ethan.
  • Kawakami M; Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mustachio LM; Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rodriguez-Canales J; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mino B; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Roszik J; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tong P; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee JJ; Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Myung JH; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Heymach JV; Department of Biopharmaceutical Sciences, College of Pharmacy, The University of Illinois, Chicago, IL, USA.
  • Johnson FM; Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hong S; Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zheng L; Department of Biopharmaceutical Sciences, College of Pharmacy, The University of Illinois, Chicago, IL, USA.
  • Hu S; Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Villalobos PA; Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
  • Behrens C; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wistuba I; Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Freemantle S; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu X; Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
  • Dmitrovsky E; Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Natl Cancer Inst ; 109(6)2017 06 01.
Article en En | MEDLINE | ID: mdl-28376145
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfoproteínas / Adenosina / Péptidos y Proteínas de Señalización Intracelular / Inhibidores de Proteínas Quinasas / Quinasa 2 Dependiente de la Ciclina / Anafase / Neoplasias Pulmonares Límite: Animals / Humans / Male Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfoproteínas / Adenosina / Péptidos y Proteínas de Señalización Intracelular / Inhibidores de Proteínas Quinasas / Quinasa 2 Dependiente de la Ciclina / Anafase / Neoplasias Pulmonares Límite: Animals / Humans / Male Idioma: En Año: 2017 Tipo del documento: Article